Gilead Sciences CEO Daniel O'Day's 2020 pay falls 35% to $19M
Gilead Sciences reports 2020 executive compensation
By ExecPay News
Published: March 30, 2021
Gilead Sciences reported fiscal year 2020 executive compensation information on March 30, 2021.
In 2020, five executives at Gilead Sciences received on average a compensation package of $9.1M, a 5% increase compared to previous year.
Average pay of disclosed executives at Gilead Sciences
Daniel P. O'Day, Chief Executive Officer, received $19M in total, which decreased by 35% compared to 2019. 44% of O'Day's compensation, or $8.4M, was in stock awards. O'Day also received $4.7M in non-equity incentive plan, $3.1M in option awards, $1.7M in salary, as well as $1.1M in other compensation.
For fiscal year 2020, the median employee pay was $250,190 at Gilead Sciences. Therefore, the ratio of Daniel P. O'Day's pay to the median employee pay was 76 to one.
Johanna Mercier, Chief Commercial Officer, received a compensation package of $7.8M, which decreased by 3% compared to previous year. 26% of the compensation package, or $2M, was in stock awards.
Merdad V. Parsey, Chief Medical Officer, earned $7.2M in 2020, a 130% increase compared to previous year.
Andrew D. Dickinson, Chief Financial Officer, received $5.8M in 2020, which increases by 4% compared to 2019.
Brett A. Pletcher, General Counsel, earned $5.7M in 2020, a 13% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 30, 2021.